(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Date of event, test date: dates estimated.(udi#): in the absence of a reported part number, the udi cannot be calculated.The device was not returned for analysis.The lot history record for this product could not be reviewed because the product was not returned for evaluation and the lot number was not reported.Based on the information reviewed, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.The reported patient effects of hemorrhage, hypertension, myocardial infarction, worsening heart failure and cardiac perforation are listed in the mitraclip system instructions for use as known possible complications associated with mitraclip procedures.There is no indication of a product quality issue with respect to manufacture, design or labeling.Attachment titled: iatrogenic atrial septal defect closure after transseptal mitral valve interventions.
|
This is filed to report serious adverse events.It was reported through a research article, that post mitraclip procedure, where patients were re-hospitalized with serious complications.The complications included intracranial hemorrhage, hypertension, myocardial infarction, heart failure, atrial perforation, which required additional treatment.Details are listed in the article titled: iatrogenic atrial septal defect closure after transseptal mitral valve interventions.No additional information was provided.
|